The global red ribbon

December 2010
New Internationalist;Dec2010, Issue 438, p8
The article discusses the global impact of AIDS, access to antiretroviral treatment, and HIV testing.


Related Articles

  • Antiretroviral Therapy Regimens for Neuro-AIDS. Arendt, G.; von Giesen, H.J. // Current Drug Targets - Infectious Disorders;Sep2002, Vol. 2 Issue 3, p187 

    In the era of highly active antiretroviral therapy (HAART) the central nervous system (CNS) becomes increasingly important as a sanctuary site for the human immunodeficiency virus (HIV-1). HIV-1-associated brain disease is subdivided into the minor cognitive / motor disorder, the minor cognitive...

  • Pediatric HIV infection guidelines are revised.  // AIDS Alert;Oct2008, Vol. 23 Issue 10, p114 

    The article cites the revisions in the "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection."

  • HIV Chemoprophylaxis: New optimism and new challenges. Mayer, Kenneth // Bay Windows;12/2/2010, Vol. 28 Issue 51, p1 

    The article focuses on the findings of a research published in the "New England Journal of Medicine" which stated that taking a daily antiretroviral pill can protect HIV-uninfected men who have sexual relations with men from becoming infected.

  • Influence of Geographical Origin and Ethnicity on Mortality in Patients on Antiretroviral Therapy in Canada, Europe, and the United States.  // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1800 

    In 55 602 human immunodeficiency virus–positive patients from Canada, Europe, and the United States, the lower mortality found in migrants—largely due to non-AIDS causes—suggests “healthy migrant” effects, whereas the higher mortality of First Nations...

  • Prognostic factors for the survival of patients with AIDS cholangiopathy Ko, Wei-Fang; Cello, John P.; Rogers, Stanley J.; Lecours, Anthony // American Journal of Gastroenterology;Oct2003, Vol. 98 Issue 10, p2176 

    : ObjectivesAIDS cholangiopathy, once considered to have extremely poor prognosis, is now rarely fatal. This study was designed to assess the survival of patients with AIDS cholangiopathy and investigate prognostic variables, especially in the era of highly active antiretroviral therapy...

  • Shortage of antiretrovirals in Uganda.  // PharmacoEconomics & Outcomes News;8/7/2010, Issue 609, p4 

    The article reports on the shortage of antiretroviral drugs in Uganda that led to the failure of treating some patients newly diagnosed with HIV infection of AIDS.

  • Hybrid Canonical-Correlation Neural-Network Approach Applied to Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors (HEPT Derivatives). Mager, Peter P.; Berkhout, B. // Current Medicinal Chemistry;Sep2003, Vol. 10 Issue 17, p1643 

    Beneficial antiviral HIV-1 chemotherapy is associated with adverse reactions. To optimize the desired actions and to lower the side effects of nonnucleoside HIV-1 reverse transcriptase (RT) inhibitors (NNRTIs), quantitative structure-activity relationships (QSARs) were studied by using a series...

  • Inhibiting HIV-1 Entry with Fusion Inhibitors. Baldwin, C.E.; Saunders, R.W.; Berkhout, B. // Current Medicinal Chemistry;Sep2003, Vol. 10 Issue 17, p1633 

    In recent years, tremendous progress has been made in understanding the HIV- 1 entry process in which the viral and cellular membranes are fused, resulting in the subsequent delivery of the viral genome into the host cell. The mechanistic insight gained from these studies has led to the...

  • Virus Entry as a Target for Anti-HIV Intervention. Este, Jose A. // Current Medicinal Chemistry;Sep2003, Vol. 10 Issue 17, p1617 

    The replicative cycle of the human immunodeficiency virus (HIV) can be interrupted at several stages. Until recently only the viral reverse transcriptase and protease were the only enzymes targeted by antiretroviral agents. However, the first HIV entry inhibitor (T-20, Enfuvirtide, Fuseon) to be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics